Concert Pharmaceuticals, Inc.
CNCEDelisted Mar 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367920
Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.
Holders of 5% or more of CNCE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Concert Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Concert Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Concert Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 13, 2022 | Bank of America Corp | 13G/AOld format | – | – | – | SEC |
| Nov 15, 2021 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Jul 12, 20218:29 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Dimensional Fund Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Ingalls & Snyder LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 20215:06 PM ET | Bank of America Corp | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20212:56 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Concert Pharmaceuticals, Inc. shares.
No Form 144 notices for Concert Pharmaceuticals, Inc. are on file.